HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test
Test Name: HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test
Test Components: IgG antibodies against HLA class I molecules, C1q-fixing antibodies
Test Price: 7960.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample.
Report Delivery: 10-12 days
Method: Luminex X-Map technology
Test Type: Transplantation pathology
Doctor: Nephrologist, Hematologist
Test Department: DNA Labs UAE
Pre Test Information: Provide brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample.
What is the HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test?
The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is a laboratory test used to detect the presence of specific antibodies in the blood that can cause rejection of transplanted organs. This test measures the level of IgG antibodies against human leukocyte antigen (HLA) class I molecules and screens for the presence of C1q-fixing antibodies. C1q is a protein that binds to IgG antibodies and activates the complement system, leading to tissue damage and rejection of the transplanted organ.
Why is the HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test performed?
The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is typically performed before and after organ transplantation to monitor the patient’s immune response to the transplanted organ. If the test shows the presence of high levels of HLA antibodies or C1q-fixing antibodies, it indicates an increased risk of rejection and the need for closer monitoring and treatment.
How is the HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test conducted?
The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test involves taking a blood sample from the patient and analyzing it in a laboratory using Luminex X-Map technology. The results of the test are usually reported as a numerical value, indicating the level of antibodies present in the blood. A positive result indicates the presence of HLA antibodies or C1q-fixing antibodies, while a negative result indicates the absence of these antibodies.
Conclusion
The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is an important tool for monitoring the immune response of transplant patients and guiding treatment decisions to prevent rejection of the transplanted organ. It is offered by DNA Labs UAE at a cost of 7960.0 AED. If you require this test, make sure to provide a brief clinical history and HLA typing report of the donor/donors if it is a pre or post transplantation sample.
Test Name | HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test |
---|---|
Components | |
Price | 7960.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Give brief clinical history and HLA typing report of Donor\/Donors if Pre or Post transplantation sample. |
Report Delivery | 10-12 days |
Method | Luminex X-Map technology |
Test type | Transplantation pathology |
Doctor | Nephrologist, Hematologist |
Test Department: | |
Pre Test Information | Give brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample. |
Test Details | HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is a laboratory test used to detect the presence of specific antibodies in the blood that can cause rejection of transplanted organs. The test measures the level of IgG antibodies against human leukocyte antigen (HLA) class I molecules and screens for the presence of C1q-fixing antibodies. C1q is a protein that binds to IgG antibodies and activates the complement system, leading to tissue damage and rejection of the transplanted organ. The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is typically performed before and after organ transplantation to monitor the patient’s immune response to the transplanted organ. If the test shows the presence of high levels of HLA antibodies or C1q-fixing antibodies, it indicates an increased risk of rejection and the need for closer monitoring and treatment. The test involves taking a blood sample from the patient and analyzing it in a laboratory. The results of the test are usually reported as a numerical value, indicating the level of antibodies present in the blood. A positive result indicates the presence of HLA antibodies or C1q-fixing antibodies, while a negative result indicates the absence of these antibodies. Overall, the HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is an important tool for monitoring the immune response of transplant patients and guiding treatment decisions to prevent rejection of the transplanted organ. |